Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort descending
Jul
27
2018
Secretary Azar Says HHS Will Reform Health Privacy Regulations Covington & Burling LLP
Jul
18
2014
China's Legislature Releases Draft Food Safety Law for Public Comment Covington & Burling LLP
Sep
2
2014
China Issues Multiple Final Rules and Proposals to Implement Recent Revisions to its Core Medical Device Regulation Covington & Burling LLP
Oct
1
2014
Governance Challenges, Social Barriers, and the Upcoming U.S. Mission to Fight Ebola Covington & Burling LLP
Nov
2
2014
Ghana Achieves “Zero Hunger” Covington & Burling LLP
Feb
7
2015
21st Century Cures Discussion Draft Act Proposes Changes to Medical Device Regulation Covington & Burling LLP
Sep
14
2015
General Court Makes Interim Order to Protect Confidentiality in Pari Pharma Transparency Case Covington & Burling LLP
Aug
3
2016
Italian Medicines Agency Publishes New Concept Paper on Biosimilars Covington & Burling LLP
Jun
2
2017
The Week Ahead in the European Parliament – June 2, 2017: Double Taxation Dispute Resolution Mechanisms in the European Union, Environmental Liability, JURI Covington & Burling LLP
Jan
22
2018
FDA Announces Broad Plan to Improve and Expedite Dissemination of Recall Information to Consumers Covington & Burling LLP
Jan
29
2018
Recent Support of Countermeasure Development Poised to Continue in Reauthorization of PAHPA Covington & Burling LLP
Sep
2
2014
EU Court Of Justice Further Clarifies Definition Of Medicinal Products – And Raises New Questions Covington & Burling LLP
Sep
13
2014
Looking Towards the Future of Pharmaceuticals in Africa Covington & Burling LLP
Oct
10
2014
FDA Finalizes Guidance for Management of Cybersecurity in Medical Devices Covington & Burling LLP
Jan
16
2015
FDA Publishes Draft Guidances Describing General Wellness Claims and Risk-Based Classification of Accessories Covington & Burling LLP
Feb
2
2015
EMA Transparency Policy – EMA Launches Public Consultation On The Publication Of Information Under The New EU Clinical Trials Regulation Covington & Burling LLP
Apr
20
2015
China FDA Focuses on Enforcement of Medical Device Good Manufacturing Practices Covington & Burling LLP
Sep
16
2015
CDRH Schedules Next Generation Sequencing Workshops Covington & Burling LLP
Jul
20
2016
Italian Administrative Court Finds That All Non-Prescription Medicines May Be Advertised to the Public Covington & Burling LLP
Dec
9
2016
The Week Ahead in the European Parliament – December 9, 2016 Covington & Burling LLP
Dec
23
2016
Twenty-First Century Cures Act Includes HIPAA Provisions Covington & Burling LLP
Jun
5
2017
Chinese FDA Issues Groundbreaking Proposals for Medical Device Regulatory Reform Covington & Burling LLP
Jun
9
2017
Week Ahead in European Parliament – June 9, 2017: Committee on Economic and Monetary Affairs; Committee on Legal Affairs; ENVI Covington & Burling LLP
Sep
5
2017
The UK’s Life Sciences Industrial Strategy: Digital Health Implications Covington & Burling LLP
Sep
13
2014
Judge Requires PhRMA To Initiate New 340B Orphan Drug Lawsuit to Challenge Interpretive Rule Covington & Burling LLP
Sep
25
2014
Recent Settlement Highlights Importance of Tracing Country of Origin When Selling Medical Devices to the U.S. Government Covington & Burling LLP
Oct
11
2014
Pharmaceutical Research and Manufacturers of America (PhRMA) Filed Suit Today Seeking to Invalidate the 340B Orphan Drug Exclusion Interpretative Rule Covington & Burling LLP
Feb
9
2015
FDA Issues Draft Guidance on Combination Product Manufacturing Covington & Burling LLP
Mar
31
2015
German Exemptions from Mandatory Rebates for Pharma Companies Are in Line with EU State Aid Rules Covington & Burling LLP
Aug
20
2015
Italian Medicines Agency Makes Public Assessment Reports Available on its Website Covington & Burling LLP
Jul
15
2016
B2B or not B2B: Application of the NHCR to Business-to-Business Commercial Communications Covington & Burling LLP
Oct
7
2016
EU Policy Update, October 2016: Brexit and the EU’s Response; Communication and Media Policies; Energy and Climate Change Policies; Trade Policy and Sanctions Covington & Burling LLP
Dec
12
2016
China Food and Drug Administration Releases Draft Classification Catalogue of Medical Devices Covington & Burling LLP
Jan
18
2017
FDA Issues Discussion Paper on Possible Regulatory Approach for Laboratory Developed Tests Covington & Burling LLP
Apr
10
2017
The Week Ahead in the European Parliament – April 7, 2017 Covington & Burling LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins